线粒体核糖体蛋白12在肾透明细胞癌中的研究进展
Research Progress of MRPL12 in Clear Cell Renal Cell Carcinoma
DOI: 10.12677/ACM.2024.141210, PDF,  被引量   
作者: 苏 桐：山东大学齐鲁医学院，山东 济南；济南市中心医院肾内科，山东 济南
关键词: 线粒体核糖体蛋白；MRPL12；肾透明细胞癌；线粒体生物合成；Mitochondrial Ribosomal Protein； MRPL12； ccRCC； Mitochondrial Biosynthesis
摘要: 肾细胞癌(renal cell carcinoma, RCC)是起源于肾小管上皮的恶性肿瘤，占肾脏恶性肿瘤的80%~90%，最常见的组织病理类型为透明细胞癌。线粒体核糖体蛋白12 (Mitochondrial ribosomal protein L7/L12, MRPL12)是哺乳动物中鉴定出来的第一种线粒体核糖体蛋白。近年来，线粒体作为潜在的癌症治疗靶点受到了广泛关注。MRPL12作为调节线粒体生物合成及能量代谢的关键蛋白，是线粒体核糖体蛋白中目前报道的唯一可以调控线粒体mtDNA转录和生物合成的蛋白。本研究就MRPL12分子对线粒体的调控作用进行讨论，通过生信分析预测评估MRPL12与肾透明细胞癌的相关性，有助于进一步探究MRPL12在肾透明细胞癌中的分子机制和功能。
Abstract: Renal cell carcinoma (RCC) is a malignant tumor originating from the epithelium of renal tubules, accounting for 80% to 90% of renal malignancies, and the most common histopathological type is clear cell carcinoma. Mitochondrial ribosomal protein L7/L12 (MRPL12) is the first mitochondrial ribosomal protein identified in mammals. In recent years, mitochondria have received much atten-tion as potential targets for cancer therapy. MRPL12, as a key protein regulating mitochondrial bi-osynthesis and energy metabolism, is the only mitochondrial ribosomal protein reported to regu-late mitochondrial mtDNA transcription and biosynthesis. In this study, we provide an overview on the regulatory role of MRPL12 on mitochondria, and assess the correlation between MRPL12 and renal clear cell carcinoma by biological information analysis, which will help to further explore the molecular mechanism and function of MRPL12 in ccRCC.
文章引用：苏桐. 线粒体核糖体蛋白12在肾透明细胞癌中的研究进展[J]. 临床医学进展, 2024, 14(1): 1462-1469. https://doi.org/10.12677/ACM.2024.141210

参考文献

[1] Zong, W.X., Rabinowitz, J.D. and White E. (2016) Mitochondria and Cancer. Molecular Cell, 61, 667-676. [Google Scholar] [CrossRef] [PubMed]
[2] Missiroli, S., Perrone, M., Genovese, I., et al. (2020) Cancer metabolism and mitochondria: Finding novel mechanisms to fight tumours. eBioMedicine, 59, Article ID: 102943. [Google Scholar] [CrossRef] [PubMed]
[3] Liu, Y., Sun, H., Li, X., et al. (2021) Identification of a Three-RNA Binding Proteins (RBPs) Signature Predicting Prognosis for Breast Cancer. Frontiers in Oncology, 11, Ar-ticle ID: 663556. [Google Scholar] [CrossRef] [PubMed]
[4] Hu, Y., Liu, Y., Ma, C., et al. (2023) MRPL12 Acts as A Novel Prognostic Biomarker Involved in Immune Cell Infiltration and Tumor Progression of Lung Adenocar-cinoma. International Journal of Molecular Sciences, 24, 2762. [Google Scholar] [CrossRef] [PubMed]
[5] Frei, C., Galloni, M., Hafen, E., et al. (2005) The Drosophila Mito-chondrial Ribosomal Protein mRpL12 Is Required for Cyclin D/Cdk4-Driven Growth. The EMBO Journal, 24, 623-634. [Google Scholar] [CrossRef] [PubMed]
[6] Surovtseva, Y.V., Shutt, T.E., Cotney, J., et al. (2011) Mitochon-drial Ribosomal Protein L12 Selectively Associates with Human Mitochondrial RNA Polymerase to Activate Transcrip-tion. PANS, 108, 17921-17926. [Google Scholar] [CrossRef] [PubMed]
[7] Ma, Y., Zhu, S., Lv, T., et al. (2020) SQSTM1/p62 Controls mtDNA Expression and Participates in Mitochondrial Energetic Adaption via MRPL12. iScience, 23, Article ID: 101428. [Google Scholar] [CrossRef] [PubMed]
[8] Attardi, G. and Schatz, G. (1988) Biogenesis of Mitochondria. An-nual Review of Cell Biology, 4, 289-333. [Google Scholar] [CrossRef] [PubMed]
[9] O’Brien, T.W. and Kalf, G.F. (1967) Ribosomes from Rat Liver Mitochondria. I. Isolation Procedure and Contamination Studies. Journal of Biological Chemistry, 242, 2172-2179. [Google Scholar] [CrossRef] 
[10] O’Brien, T.W. and Kalf, G.F. (1967) Ribosomes from Rat Liver Mitochondira. II. Partial Characterization. Journal of Biological Chemistry, 242, 2180-2185. [Google Scholar] [CrossRef] 
[11] O’Brien, TW. (1971) The General Occurrence of 55 S Ri-bosomes in Mammalian Liver Mitochondria. Journal of Biological Chemistry, 246, 3409-3417. [Google Scholar] [CrossRef] 
[12] Gopisetty, G. and Thangarajan, R. (2016) Mammalian Mito-chondrial Ribosomal Small Subunit (MRPS) Genes: A Putative Role in Human Disease. Gene, 589, 27-35. [Google Scholar] [CrossRef] [PubMed]
[13] Kenmochi, N., Suzuki, T., Uechi, T., et al. (2001) The Human Mi-tochondrial Ribosomal Protein Genes: Mapping of 54 Genes to the Chromosomes and Implications for Human Disorders. Genomics, 77, 65-70. [Google Scholar] [CrossRef] [PubMed]
[14] Marty, L. and Fort, P. (1996) A Delayed-Early Response Nuclear Gene Encoding MRPL12, the Mitochondrial Homologue to the Bacterial Translational Regulator L7/L12 Protein. Journal of Biological Chemistry, 271, 11468-11476. [Google Scholar] [CrossRef] [PubMed]
[15] Marty, L., Taviaux, S. and Fort, P. (1997) Expression and Human Chromosomal Localization to 17q25 of the Growth-Regulated Gene Encoding the Mitochondrial Ribosomal Protein MRPL12. Genomics, 41, 453-457. [Google Scholar] [CrossRef] [PubMed]
[16] Kühl, I., Miranda, M., Posse, V., et al. (2016) POLRMT Regulates the Switch between Replication Primer Formation and Gene Expression of Mammalian mtDNA. Science Advances, 2, e1600963. [Google Scholar] [CrossRef] [PubMed]
[17] Nouws, J., Goswami, A.V., Bestwick, M., et al. (2016) Mitochondrial Ribosomal Protein L12 Is Required for POLRMT Stability and Exists as Two Forms Generated by Alter-native Proteolysis during Import. Journal of Biological Chemistry, 291, 989-997. [Google Scholar] [CrossRef] 
[18] Halenova, T., Savchuk, O., Ostapchenko, L., et al. (2017) P62 Plasmid Can Alleviate Diet-Induced Obesity and Metabolic Dysfunctions. Oncotarget, 8, 56030-56040. [Google Scholar] [CrossRef] [PubMed]
[19] Serre, V., Rozanska, A., Beinat, M., et al. (2013) Mutations in Mi-tochondrial Ribosomal Protein MRPL12 Leads to Growth Retardation, Neurological Deterioration and Mitochondrial Translation Deficiency. Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1832, 1304-1312. [Google Scholar] [CrossRef] [PubMed]
[20] Koc, E.C., Haciosmanoglu, E., Claudio, P.P., et al. (2015) Im-paired Mitochondrial Protein Synthesis in Head and Neck Squamous Cell Carcinoma. Mitochondrion, 24, 113-121. [Google Scholar] [CrossRef] [PubMed]
[21] Min, S., Lee, Y.K., Hong, J., et al. (2021) MRPS31 Loss Is a Key Driver of Mitochondrial Deregulation and Hepatocellular Carcinoma Aggressiveness. Cell Death & Disease, 12, Article No. 1076. [Google Scholar] [CrossRef] [PubMed]
[22] Ye, H. and Zhang, N. (2021) Identification of the Upregulation of MRPL13 as a Novel Prognostic Marker Associated with Overall Survival Time and Immunotherapy Response in Breast Cancer. Computational and Mathematical Methods in Medicine, 2021, Article ID: 1498924. [Google Scholar] [CrossRef] [PubMed]
[23] Best, C.J., Gillespie, J.W., Yi, Y., et al. (2005) Molecular Alterations in Primary Prostate Cancer after Androgen Ablation Therapy. Clinical Cancer Research, 11, 6823-6834. [Google Scholar] [CrossRef] 
[24] Chen, Y., Cairns, R., Papandreou, I., et al. (2009) Oxygen Consumption Can Regulate the Growth of Tumors, a New Perspective on the Warburg Effect. PLOS ONE, 4, e7033. [Google Scholar] [CrossRef] [PubMed]
[25] Vasan, K., Werner, M. and Chandel, N.S. (2020) Mitochondrial Metabolism as a Target for Cancer Therapy. Cell Metabolism, 32, 341-352. [Google Scholar] [CrossRef] [PubMed]
[26] Sainero-Alcolado, L., Liaño-Pons, J., Ruiz-Pérez, M.V., et al. (2022) Targeting Mitochondrial Metabolism for Precision Medicine in Cancer. Cell Death & Differentiation, 29, 1304-1317. [Google Scholar] [CrossRef] [PubMed]
[27] Wettersten, H.I., Aboud, O.A., Lara Jr., P.N., et al. (2017) Metabolic Reprogramming in Clear Cell Renal Cell Carcinoma. Nature Reviews Nephrology, 13, 410-419. [Google Scholar] [CrossRef] [PubMed]
[28] Chakraborty, S., Balan, M., Sabarwal, A., et al. (2021) Metabolic Re-programming in Renal Cancer: Events of a Metabolic Disease. Biochimica et Biophysica Acta (BBA)—Reviews on Cancer, 1876, Article ID: 188559. [Google Scholar] [CrossRef] [PubMed]

为你推荐